Mubadala Bio News and Activities

Mubadala Bio is owned by Mubadala. Mubadala has a direct presence in 6 countries.

Mubadala has 18 subsidiaries including CI Assante Wealth Management, CI Financial and CI Global Asset Management.

They are in:

• Financial Services32%
• Holding11%
• Other58%

View the org chart displaying its 11 main executives

Most searched biographies at Mubadala Bio

• Essam Mohamed, Chief Executive Officer
• Michael Cleanis, Director
• Abdulla Mohamed Shadid, Director

Popular executive movements at Mubadala Bio

• Atif Azeem has joined the company as Chief Financial Officer  (posted on September 25 2025).
• Essam Mohamed has joined the company as Chief Executive Officer  (posted on September 25 2025).
• Hamad Al Marzooqi has joined the company as Group Deputy Chief Executive Officer  (posted on September 25 2025).

Create your alert
to follow the executive moves at Mubadala Bio.

Mubadala has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Mubadala Bio

Social media about Mubadala Bio

• Mubadala Bio on Wikipedia, Google News & Yahoo Finance
• Mubadala Bio on LinkedIn, X (Twitter) & YouTube